isolated partial cerebellar vermis agenesis
ORPHA: 2692091 Treatment Available
Overview
human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Vigabatrin Orphan | Oral tablet 500mg; Oral powder for solution 500mg sachets | FDA Approved, EMA Approved | 6 | 14d |
Classification & Codes
Orphanet Code
ORPHA:269209isolated partial cerebellar vermis agenesis
| Orphanet | ORPHA:269209 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO